Large End User Market: The market for the Company’s rehabilitative devices is significant.
There are approximately 17.5 million patients requiring upper limb rehabilitation, most of them
(70%) stroke survivors, in North America, EU and Japan. Each year, an additional 1.17 million
patients join these markets, representing a 6.6% growth rate. As most of the patients are stroke
survivors, the growth rate is likely to increase resulting from an aging population and the
increased survivor rates among stroke victims.
Similarly, with respect to the Sleeve, about half of stroke survivors require daily assistance. That
translates into a potential market of 8.75 million patients with an annual growth of 580,000
patients, or 6.6% per annum growth rate.
Potential Purchasers: Developers and manufacturers of durable and home medical
equipment as well as operators of rehabilitation centers and distributors of rehabilitation devices
are potential purchasers of the Company’s proposed diagnostic and rehabilitation equipment and
assistive devices.
Market Penetration Strategy: Building an American commercial entity in the US in Atlanta
Georgia and approaching clinics and hospitals at first stage healthcare providers and
rehabilitation facilities and others involved in rehabilitating patients, by leveraging the publicity and
interest garnered through clinical and academic research on the OR. Muscle Tech will seek to
partner with established companies serving large customer bases that can offer value added
services to the sales process. Our strategic focus on providers of rehabilitation and home care
services in the US which represents in excess of 50% of the worldwide market for rehabilitation
devices.
Licensing Opportunities: The Company believes that its proprietary Artificial Muscle
technology with its unique lightweight, controllable properties could also have significant potential
uses in non-medical areas such as robotics, avionics, and aerospace industries.
There are approximately 17.5 million patients requiring upper limb rehabilitation, most of them
(70%) stroke survivors, in North America, EU and Japan. Each year, an additional 1.17 million
patients join these markets, representing a 6.6% growth rate. As most of the patients are stroke
survivors, the growth rate is likely to increase resulting from an aging population and the
increased survivor rates among stroke victims.
Similarly, with respect to the Sleeve, about half of stroke survivors require daily assistance. That
translates into a potential market of 8.75 million patients with an annual growth of 580,000
patients, or 6.6% per annum growth rate.
Potential Purchasers: Developers and manufacturers of durable and home medical
equipment as well as operators of rehabilitation centers and distributors of rehabilitation devices
are potential purchasers of the Company’s proposed diagnostic and rehabilitation equipment and
assistive devices.
Market Penetration Strategy: Building an American commercial entity in the US in Atlanta
Georgia and approaching clinics and hospitals at first stage healthcare providers and
rehabilitation facilities and others involved in rehabilitating patients, by leveraging the publicity and
interest garnered through clinical and academic research on the OR. Muscle Tech will seek to
partner with established companies serving large customer bases that can offer value added
services to the sales process. Our strategic focus on providers of rehabilitation and home care
services in the US which represents in excess of 50% of the worldwide market for rehabilitation
devices.
Licensing Opportunities: The Company believes that its proprietary Artificial Muscle
technology with its unique lightweight, controllable properties could also have significant potential
uses in non-medical areas such as robotics, avionics, and aerospace industries.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Market